<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Markmap</title>
<style>
* {
  margin: 0;
  padding: 0;
}
#mindmap {
  display: block;
  width: 100vw;
  height: 100vh;
}
</style>

<style type="text/css">
  body{
  background-image:url(./logo.jpg);   
  background-repeat:no-repeat;             
  background-size:100% auto; 
                
  }
  </style>

<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.1.5/dist/style.min.css">
</head>
<body>
<svg id="mindmap"></svg>

<script src="./npm.js"></script>
<script src="./markmap-view.js"></script>
<!-- <script src="./markmap-toolbar.js"></script> -->


<script>(r => {
                setTimeout(r);
              })(() => {
  const {
    markmap,
    mm
  } = window;
  const toolbar = new markmap.Toolbar();
  toolbar.attach(mm);
  const el = toolbar.render();
  el.setAttribute('style', 'position:absolute;bottom:20px;right:20px');
  document.body.append(el);
})</script>


<script>((getMarkmap, getOptions, data) => {
        const {
          Markmap
        } = getMarkmap();
        window.mm = Markmap.create('svg#mindmap', getOptions == null ? void 0 : getOptions(), data);
      })(() => window.markmap,null,{"t":"heading","d":1,"p":{"lines":[0,1]},"v":"新版支气管哮喘","c":[{"t":"heading","d":2,"p":{"lines":[2,3]},"v":"病理","c":[{"t":"heading","d":3,"p":{"lines":[4,5]},"v":"气道慢性炎症","c":[{"t":"list_item","d":5,"p":{"lines":[6,7]},"v":"气道上皮下炎性细胞浸润","c":[{"t":"list_item","d":7,"p":{"lines":[8,9]},"v":"肥大细胞"},{"t":"list_item","d":7,"p":{"lines":[9,10]},"v":"嗜酸性粒细胞"},{"t":"list_item","d":7,"p":{"lines":[10,11]},"v":"巨噬细胞"},{"t":"list_item","d":7,"p":{"lines":[11,12]},"v":"淋巴细胞"},{"t":"list_item","d":7,"p":{"lines":[12,13]},"v":"中性粒细胞"}]},{"t":"list_item","d":5,"p":{"lines":[13,14]},"v":"支气管平滑肌痉挛"},{"t":"list_item","d":5,"p":{"lines":[14,15]},"v":"纤毛上皮细胞脱落"},{"t":"list_item","d":5,"p":{"lines":[15,16]},"v":"杯状细胞增殖"},{"t":"list_item","d":5,"p":{"lines":[16,17]},"v":"细胞分泌物增加"},{"t":"list_item","d":5,"p":{"lines":[17,18]},"v":"长期反复发作引起气道重构","c":[{"t":"list_item","d":7,"p":{"lines":[18,19]},"v":"平滑肌肥大增生"},{"t":"list_item","d":7,"p":{"lines":[19,20]},"v":"气道上皮粘液化生"},{"t":"list_item","d":7,"p":{"lines":[20,21]},"v":"上皮下胶原沉积"}]}]}]},{"t":"heading","d":2,"p":{"lines":[22,23]},"v":"临床表现","c":[{"t":"heading","d":3,"p":{"lines":[24,25]},"v":"症状","c":[{"t":"heading","d":4,"p":{"lines":[26,27]},"v":"典型症状","c":[{"t":"list_item","d":6,"p":{"lines":[28,29]},"v":"发作性伴有哮鸣音的呼气性呼吸困难"}]},{"t":"heading","d":4,"p":{"lines":[30,31]},"v":"重要临床特征","c":[{"t":"list_item","d":6,"p":{"lines":[32,33]},"v":"夜间及凌晨发作或加重"}]},{"t":"heading","d":4,"p":{"lines":[34,35]},"v":"咳嗽变异性哮喘"},{"t":"heading","d":4,"p":{"lines":[36,37]},"v":"胸闷变异性哮喘"}]},{"t":"heading","d":3,"p":{"lines":[38,39]},"v":"体征","c":[{"t":"list_item","d":5,"p":{"lines":[40,41]},"v":"双肺闻及广泛哮鸣音"},{"t":"list_item","d":5,"p":{"lines":[42,43]},"v":"严重哮喘发作哮鸣音减弱或消失"}]}]},{"t":"heading","d":2,"p":{"lines":[44,45]},"v":"实验室检查与其他检查","c":[{"t":"heading","d":3,"p":{"lines":[46,47]},"v":"痰嗜酸性粒细胞计数增高（&gt;2.5%）"},{"t":"heading","d":3,"p":{"lines":[48,49]},"v":"肺功能检查","c":[{"t":"list_item","d":5,"p":{"lines":[50,51]},"v":"通气功能检测","c":[{"t":"list_item","d":7,"p":{"lines":[51,52]},"v":"阻塞性通气功能障碍","c":[{"t":"list_item","d":9,"p":{"lines":[52,53]},"v":"FEV<sub>1</sub>/FVC% &lt; 70% FEV<sub>1</sub>低于正常值80%"}]}]},{"t":"list_item","d":5,"p":{"lines":[54,55]},"v":"支气管激发试验（BPT）","c":[{"t":"list_item","d":7,"p":{"lines":[55,56]},"v":"适用于非哮喘发作期间 FEV<sub>1</sub>在预计值70%以上"},{"t":"list_item","d":7,"p":{"lines":[56,57]},"v":"阳性","c":[{"t":"list_item","d":9,"p":{"lines":[57,58]},"v":"FEV<sub>1</sub>下降≥20%"}]}]},{"t":"list_item","d":5,"p":{"lines":[59,60]},"v":"支气管舒张试验（BDT）","c":[{"t":"list_item","d":7,"p":{"lines":[60,61]},"v":"阳性","c":[{"t":"list_item","d":9,"p":{"lines":[61,62]},"v":"FEV<sub>1</sub>较用药前增加12%"},{"t":"list_item","d":9,"p":{"lines":[62,63]},"v":"FEV<sub>1</sub> 绝对值增加大于200ml"}]}]},{"t":"list_item","d":5,"p":{"lines":[64,65]},"v":"呼吸流量峰值（PEF）及其变异率测定","c":[{"t":"list_item","d":7,"p":{"lines":[65,66]},"v":"气道可逆性的改变","c":[{"t":"list_item","d":9,"p":{"lines":[66,67]},"v":"PEF平均每日昼夜变异率&gt;20%"}]}]}]},{"t":"heading","d":3,"p":{"lines":[68,69]},"v":"胸部X线/CT检查","c":[{"t":"list_item","d":5,"p":{"lines":[69,70]},"v":"胸部X线可见两肺透亮度增加，呈过度通气状态，缓解期多无明显异常"},{"t":"list_item","d":5,"p":{"lines":[70,71]},"v":"胸部CT在部分病人可见支气管壁增厚，黏液阻塞"}]},{"t":"heading","d":3,"p":{"lines":[72,73]},"v":"特异性变应原检测","c":[{"t":"list_item","d":5,"p":{"lines":[74,75]},"v":"外周血变应原特异性IgE增高"}]},{"t":"heading","d":3,"p":{"lines":[76,77]},"v":"动脉血气分析","c":[{"t":"list_item","d":5,"p":{"lines":[77,78]},"v":"轻中度","c":[{"t":"list_item","d":7,"p":{"lines":[78,79]},"v":"PaCo<sub>2</sub>下降 呼吸性碱中毒"}]},{"t":"list_item","d":5,"p":{"lines":[79,80]},"v":"重度","c":[{"t":"list_item","d":7,"p":{"lines":[80,81]},"v":"缺氧+呼酸"}]}]},{"t":"heading","d":3,"p":{"lines":[82,83]},"v":"呼出气一氧化氮（FeNO）检测"}]},{"t":"heading","d":2,"p":{"lines":[84,85]},"v":"诊断","c":[{"t":"heading","d":3,"p":{"lines":[86,87]},"v":"诊断标准","c":[{"t":"heading","d":4,"p":{"lines":[88,89]},"v":"典型哮喘的临床症状和体征","c":[{"t":"list_item","d":6,"p":{"lines":[90,91]},"v":"反复发作喘息、气急，胸闷或咳嗽，夜间及晨间多发"},{"t":"list_item","d":6,"p":{"lines":[92,93]},"v":"发作时双肺可闻及散在或弥漫性哮鸣音，呼气相延长"},{"t":"list_item","d":6,"p":{"lines":[94,95]},"v":"可经治疗缓解或自行缓解"}]},{"t":"heading","d":4,"p":{"lines":[96,97]},"v":"可变气流受限的客观检查（具备其中任一条）","c":[{"t":"list_item","d":6,"p":{"lines":[98,99]},"v":"支气管舒张试验阳性"},{"t":"list_item","d":6,"p":{"lines":[100,101]},"v":"支气管激发试验阳性"},{"t":"list_item","d":6,"p":{"lines":[102,103]},"v":"平均每日PEF昼夜变异率&gt;10%或PEF周变异率&gt;20%"}]}]},{"t":"heading","d":3,"p":{"lines":[104,105]},"v":"哮喘的分期及控制水平分级","c":[{"t":"list_item","d":5,"p":{"lines":[106,107]},"v":"急性发作期","c":[{"t":"list_item","d":7,"p":{"lines":[107,108]},"v":"轻度","c":[{"t":"list_item","d":9,"p":{"lines":[108,109]},"v":"步行或上楼时气短，可有焦虑，呼吸频率轻度增加"}]},{"t":"list_item","d":7,"p":{"lines":[109,110]},"v":"中度","c":[{"t":"list_item","d":9,"p":{"lines":[110,111]},"v":"稍事活动感气短，讲话常有中断，时有焦虑，呼吸频率增加，使用支气管舒张剂后PEF占预计值的60%-80%，SaO<sub>2</sub> 91%-95%"}]},{"t":"list_item","d":7,"p":{"lines":[111,112]},"v":"重度","c":[{"t":"list_item","d":9,"p":{"lines":[112,113]},"v":"休息时感气短，端坐呼吸，只能发单字表达，常有焦虑和烦躁，大汗淋漓，呼吸频率&gt;30次/分，心率常&gt;120次/分"},{"t":"list_item","d":9,"p":{"lines":[113,114]},"v":"常有三凹征，闻及响亮弥漫的哮鸣音，使用支气管舒张剂后PEF占预计值&lt;60%或绝对值&lt;100L/min或作用时间&lt;两小时，PaO<sub>2</sub>&lt;60mmg，PaCO<sub>2</sub>&gt;45mmHg，SaO<sub>2</sub>≤90%，pH可降低"}]},{"t":"list_item","d":7,"p":{"lines":[114,115]},"v":"危重","c":[{"t":"list_item","d":9,"p":{"lines":[115,116]},"v":"病人不能讲话，嗜睡或意识模糊，胸腹运动矛盾，哮鸣音减弱甚至消失，脉率变慢或不规则，严重低氧血症和高二氧化碳血症，pH降低"}]}]},{"t":"list_item","d":5,"p":{"lines":[117,118]},"v":"慢性持续期","c":[{"t":"list_item","d":7,"p":{"lines":[119,120]},"v":"哮喘控制水平指标（过去四周）","c":[{"t":"list_item","d":9,"p":{"lines":[120,121]},"v":"日间哮喘症状&gt;2次/周"},{"t":"list_item","d":9,"p":{"lines":[121,122]},"v":"夜间因哮喘憋醒"},{"t":"list_item","d":9,"p":{"lines":[122,123]},"v":"使用缓解药物次数&gt;2次/周"},{"t":"list_item","d":9,"p":{"lines":[123,124]},"v":"哮喘引起的活动受限"}]},{"t":"list_item","d":7,"p":{"lines":[124,125]},"v":"哮喘控制水平分级","c":[{"t":"list_item","d":9,"p":{"lines":[125,126]},"v":"良好控制"},{"t":"list_item","d":9,"p":{"lines":[126,127]},"v":"部分控制"},{"t":"list_item","d":9,"p":{"lines":[127,128]},"v":"未控制"}]}]},{"t":"list_item","d":5,"p":{"lines":[129,130]},"v":"临床缓解期","c":[{"t":"list_item","d":7,"p":{"lines":[130,131]},"v":"病人无喘息、气急、胸闷、咳嗽等症状，并持续1年以上"}]}]}]},{"t":"heading","d":2,"p":{"lines":[132,133]},"v":"鉴别诊断","c":[{"t":"list_item","d":4,"p":{"lines":[134,135]},"v":"左心衰竭引起的呼吸困难"},{"t":"list_item","d":4,"p":{"lines":[136,137]},"v":"慢性阻塞性肺疾病"},{"t":"list_item","d":4,"p":{"lines":[138,139]},"v":"上气道阻塞"},{"t":"list_item","d":4,"p":{"lines":[140,141]},"v":"变体反应性支气管肺曲霉病"}]},{"t":"heading","d":2,"p":{"lines":[142,143]},"v":"并发症","c":[{"t":"list_item","d":4,"p":{"lines":[144,145]},"v":"严重发作时可并发气胸、纵隔气肿、肺不张"},{"t":"list_item","d":4,"p":{"lines":[146,147]},"v":"长期反复发作或感染可致慢性并发症，如慢阻肺、支气管扩张、间质性肺炎和肺源性心脏病"}]},{"t":"heading","d":2,"p":{"lines":[148,149]},"v":"治疗","c":[{"t":"heading","d":3,"p":{"lines":[150,151]},"v":"确定并减少危险因素接触"},{"t":"heading","d":3,"p":{"lines":[152,153]},"v":"药物治疗","c":[{"t":"heading","d":4,"p":{"lines":[154,155]},"v":"药物分类","c":[{"t":"list_item","d":6,"p":{"lines":[156,157]},"v":"糖皮质激素"},{"t":"list_item","d":6,"p":{"lines":[158,159]},"v":"β<sub>2</sub>受体激动剂"},{"t":"list_item","d":6,"p":{"lines":[160,161]},"v":"白三烯调节剂"},{"t":"list_item","d":6,"p":{"lines":[162,163]},"v":"茶碱类药物"},{"t":"list_item","d":6,"p":{"lines":[164,165]},"v":"抗胆碱药"},{"t":"list_item","d":6,"p":{"lines":[166,167]},"v":"抗IgE抗体"},{"t":"list_item","d":6,"p":{"lines":[168,169]},"v":"抗IL-5治疗"}]},{"t":"heading","d":4,"p":{"lines":[170,171]},"v":"急性发作期的治疗","c":[{"t":"list_item","d":6,"p":{"lines":[172,173]},"v":"轻度：经MDI吸入SABA"},{"t":"list_item","d":6,"p":{"lines":[174,175]},"v":"中度：吸入SABA（常用雾化吸入）"},{"t":"list_item","d":6,"p":{"lines":[176,177]},"v":"重度至危重度：持续物化吸入SABA，联合雾化吸入短效抗胆碱药、激素混悬液以及静脉茶碱类药物，吸氧"}]},{"t":"heading","d":4,"p":{"lines":[178,179]},"v":"慢性持续期的治疗","c":[{"t":"list_item","d":6,"p":{"lines":[179,180]},"v":"第1级","c":[{"t":"list_item","d":8,"p":{"lines":[180,181]},"v":"推荐不使用药物，也可选择低剂量ICS，缓解药物为SABA，按需使用"}]},{"t":"list_item","d":6,"p":{"lines":[181,182]},"v":"第2级","c":[{"t":"list_item","d":8,"p":{"lines":[182,183]},"v":"推荐使用低剂量ICS，也可选择白三烯受体拮抗剂或低剂量茶碱，缓解药物为SABA，按需使用"}]},{"t":"list_item","d":6,"p":{"lines":[183,184]},"v":"第3级","c":[{"t":"list_item","d":8,"p":{"lines":[184,185]},"v":"推荐使用低剂量ICS加LABA，也可选择中高剂量ICS，低剂量ICS加白三烯受体拮抗剂或低剂量ICS加茶碱"}]},{"t":"list_item","d":6,"p":{"lines":[185,186]},"v":"第4级","c":[{"t":"list_item","d":8,"p":{"lines":[186,187]},"v":"推荐使用中高剂量ICS加LABA，也可选择中高剂量ICS加LABA加LAMA，高剂量ICS加白三烯受体拮抗剂或高剂量ICS加茶碱"}]},{"t":"list_item","d":6,"p":{"lines":[187,188]},"v":"第5级","c":[{"t":"list_item","d":8,"p":{"lines":[188,189]},"v":"推荐加用糖皮质激素治疗，也可加用LAMA、IgE单抗或IL-5单抗"}]},{"t":"list_item","d":6,"p":{"lines":[189,190]},"v":"第3-5级的缓解药物为SABA（按需使用）或低剂量布地奈德/福莫特罗或倍氯米松/福莫特罗"}]},{"t":"heading","d":4,"p":{"lines":[191,192]},"v":"免疫疗法","c":[{"t":"list_item","d":6,"p":{"lines":[193,194]},"v":"特异性免疫治疗","c":[{"t":"list_item","d":8,"p":{"lines":[194,195]},"v":"适用于变应原明确，且在严格的环境控制和药物治疗后仍控制不良的哮喘病人。"}]},{"t":"list_item","d":6,"p":{"lines":[195,196]},"v":"非特异性免疫治疗","c":[{"t":"list_item","d":8,"p":{"lines":[196,197]},"v":"注射卡介苗及其衍生物、转移因子、疫苗等，有一定辅助疗效"}]}]}]}]}]})</script>
</body>
</html>
